Exploring natural killer cell immunology as a therapeutic strategy in lung cancer

por Hess, Jonas B., Sutherland, Kate D., Best, Sarah A.
Publicado 2021

Editorial: Overcoming drug relapse and therapy resistance in NSCLC

por Parakh, Sagun, Leong, Tracy L., Best, Sarah A., Poh, Ashleigh R.
Publicado 2023

FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium

por Best, Sarah A., Harapas, Cassandra R., Kersbergen, Ariena, Rathi, Vivek, Asselin-Labat, Marie-Liesse, Sutherland, Kate D.
Publicado 2018

From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress

por Dewdney, Brittany, Jenkins, Misty R., Best, Sarah A., Freytag, Saskia, Prasad, Krishneel, Holst, Jeff, Endersby, Raelene, Johns, Terrance G.
Publicado 2023

Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis

por Best, Sarah A., Vandenberg, Cassandra J., Abad, Etna, Whitehead, Lachlan, Guiu, Laia, Ding, Sheryl, Brennan, Margs S., Strasser, Andreas, Herold, Marco J., Sutherland, Kate D., Janic, Ana
Publicado 2020

BCKDK alters the metabolism of non-small cell lung cancer

por Wang, Yanhui, Xiao, Jiawei, Jiang, Wenna, Zuo, Duo, Wang, Xia, Jin, Yu, Qiao, Lu, An, Haohua, Yang, Lexin, Dumoulin, Daphne W., Dempke, Wolfram C. M., Best, Sarah A., Ren, Li
Publicado 2021

A pooled shRNA screen for regulators of primary mammary stem and progenitor cells identifies roles for Asap1 and Prox1

por Sheridan, Julie M, Ritchie, Matthew E, Best, Sarah A, Jiang, Kun, Beck, Tamara J, Vaillant, François, Liu, Kevin, Dickins, Ross A, Smyth, Gordon K, Lindeman, Geoffrey J, Visvader, Jane E
Publicado 2015

Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma

por Best, Sarah A., Ding, Sheryl, Kersbergen, Ariena, Dong, Xueyi, Song, Ji-Ying, Xie, Yi, Reljic, Boris, Li, Kaiming, Vince, James E., Rathi, Vivek, Wright, Gavin M., Ritchie, Matthew E., Sutherland, Kate D.
Publicado 2019

Matrix Selection for the Visualization of Small Molecules and Lipids in Brain Tumors Using Untargeted MALDI-TOF Mass Spectrometry Imaging

por Lu, Tianyao, Freytag, Lutz, Narayana, Vinod K., Moore, Zachery, Oliver, Shannon J., Valkovic, Adam, Nijagal, Brunda, Peterson, Amanda L., de Souza, David P., McConville, Malcolm J., Whittle, James R., Best, Sarah A., Freytag, Saskia
Publicado 2023

Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia

por Liu, Grace J., Cimmino, Luisa, Jude, Julian G., Hu, Yifang, Witkowski, Matthew T., McKenzie, Mark D., Kartal-Kaess, Mutlu, Best, Sarah A., Tuohey, Laura, Liao, Yang, Shi, Wei, Mullighan, Charles G., Farrar, Michael A., Nutt, Stephen L., Smyth, Gordon K., Zuber, Johannes, Dickins, Ross A.
Publicado 2014